Fresenius Kabi Canada announces that its tocilizumab biosimilar Tyenne® referencing Actemra®** (tocilizumab) is now commercially available in Canada. Tyenne® is the first and only tocilizumab ...

The British Society for Rheumatology has moved toward a life course approach when updating guidelines for several rheumatic ...

Current treatment paradigms for lupus nephritis offer significant room for improvement, according to a presenter at the ...

Patients with rheumatoid arthritis (RA) who switched from Enbrel (reference etanercept) to a biosimilar maintained remission, ...

In recent years, Dr. Manel Mejbri has actively contributed to several collaborative international research studies in the ...

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

The sCD13 protein has been previously identified by a rheumatology research team at the University of Michigan as a powerful ...

Two University of California San Diego School of Medicine physician-scientists have been elected to the Association of ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its ...

The trial is being conducted by Integral Rheumatology & Immunology Specialists (IRIS), in an outpatient setting at a ...

A new study finds that using the ISBAR communication model significantly improves bedside care quality among rheumatology and immunology nurses, supporting wider adoption in clinical handoffs.

The updated recommendations also provide guidance on antirheumatic drug use through lactation and in male patients trying to ...